Kayleigh R Marx

Kayleigh R Marx

M D Anderson Cancer Center University of Texas - Houston / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1406886
MD Anderson Cancer Center
person_outline Kayleigh R Marx's MOST POPULAR ARTICLES
1-) Clinical experience with the BCL 2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies American journal of hematology 93 (3), 401-407, 2018
2-) Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (11 …, 2015
3-) Venetoclax and BCR-ABL tyrosine kinase inhibitor combinations: outcome in patients with philadelphia chromosome-positive advanced myeloid leukemias Acta haematologica 143 (6), 567-573, 2021
4-) Isavuconazole as primary antifungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase 2 study Clinical Infectious Diseases 72 (10), 1755-1763, 2021
5-) Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (11 …, 2014